NCT03783936 Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas Status COMPLETED Phase PHASE2
NCT03764553 Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03750786 A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE3
NCT03736720 Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin Status TERMINATED Phase PHASE2
NCT03715933 Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas Status RECRUITING Phase PHASE1
NCT03711240 The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases Status UNKNOWN Phase PHASE2
NCT03703063 Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer Status UNKNOWN Phase PHASE1
NCT03684980 LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03678428 FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM Status TERMINATED Phase PHASE3
NCT03607643 A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT03563170 QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine Status WITHDRAWN Phase PHASE1/PHASE2
NCT03554109 QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine Status WITHDRAWN Phase PHASE2
NCT03522649 A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT03515941 Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers Status TERMINATED Phase EARLY_PHASE1
NCT03505320 A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03503604 A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors Status UNKNOWN Phase PHASE1